PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Statistics

Total Valuation

PMCB has a market cap or net worth of $8.30 million. The enterprise value is -$12.31 million.

Market Cap	8.30M
Enterprise Value	-12.31M

Important Dates

The next estimated earnings date is Monday, March 16, 2026, after market close.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

PMCB has 10.13 million shares outstanding. The number of shares has decreased by -15.57% in one year.

Current Share Class	10.13M
Shares Outstanding	10.13M
Shares Change (YoY)	-15.57%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.76%
Owned by Institutions (%)	6.40%
Float	8.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.16
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.60

Current Ratio	14.60
Quick Ratio	13.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.68% and return on invested capital (ROIC) is -6.60%.

Return on Equity (ROE)	-17.68%
Return on Assets (ROA)	-4.76%
Return on Invested Capital (ROIC)	-6.60%
Return on Capital Employed (ROCE)	-7.77%
Weighted Average Cost of Capital (WACC)	4.47%
Revenue Per Employee	n/a
Profits Per Employee	-$3.82M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.23% in the last 52 weeks. The beta is 0.04, so PMCB's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-49.23%
50-Day Moving Average	0.86
200-Day Moving Average	0.98
Relative Strength Index (RSI)	43.94
Average Volume (20 Days)	356,663

Short Selling Information

The latest short interest is 177,318, so 1.75% of the outstanding shares have been sold short.

Short Interest	177,318
Short Previous Month	62,893
Short % of Shares Out	1.75%
Short % of Float	2.02%
Short Ratio (days to cover)	0.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.23M
Pretax Income	-7.07M
Net Income	-7.63M
EBITDA	n/a
EBIT	-4.23M
Earnings Per Share (EPS)	-$1.11

Balance Sheet

The company has $20.61 million in cash and n/a in debt, with a net cash position of $20.61 million or $2.03 per share.

Cash & Cash Equivalents	20.61M
Total Debt	n/a
Net Cash	20.61M
Net Cash Per Share	$2.03
Equity (Book Value)	36.55M
Book Value Per Share	5.25
Working Capital	21.44M

Cash Flow

Operating Cash Flow	-4.52M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	15.57%
Shareholder Yield	15.57%
Earnings Yield	-91.97%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 12, 2021. It was a reverse split with a ratio of 1:1,499.93.

Last Split Date	Jul 12, 2021
Split Type	Reverse
Split Ratio	1:1,499.93

Scores

Altman Z-Score	n/a
Piotroski F-Score	2